MarginsXMarginsX
Home › Markets › Health Care › FEMY

Femasys Inc. (FEMY)

FEMY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.28
-8.57% on the day
Market cap
$11.1M
Nano cap
Revenue · 2025
$2.3M
+40.8% on 2024
Net income · 2025
-$18.6M
-812.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/0001140361-26-012375-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerFEMY on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001339005
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.3M
Net income-$18.6M
Operating income-$17.6M
Net margin-812.3%
Operating margin-767.0%
Revenue growth+40.8%
Cash$9.3M
Total assets$20.7M
P/E (computed)Net income was not positive
P/S (computed)4.8×

Warning signs

Cash runway
1.0 months
$1.4M cash at June 30, 2026
Share count, 1 year
+196.0%
2025-11-13 to 2026-11-12 · +699.7% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$74K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$1.4M cash; operating cash flow -$4.4M a quarter.Report 2026-06-30
Shares outstanding8,656,277 (2026-11-12); 58,479,824 a year earlier; 21,649,623 three years earlier. 1y figure adjusted for split (1-for-20 overall); 3y figure adjusted for split (1-for-20 overall).Cover page 2026-11-12
Reverse splits, 3 years1; latest 1-for-20 on 2026-06-08Source 2026-06-08
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-09-03
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-15
AuditorKPMG LLP, Atlanta, Georgia, United StatesPCAOB Form AP 2026-04-28
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $74K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$332K-$4.5M-$3.9M$1.4M$3.5M$2.3M10-Q 2026-08-14
Q1 2026
2026-03-31
$425K$846K-$4.1M$5.4M$3.3M$2.4M10-Q 2026-05-08
Q4 2025
2025-12-31
$813K-$4.0M-$4.2M$9.3M$3.2M$2.3M10-K 2026-03-31
Q3 2025
2025-09-30
$729K-$4.2M-$5.4M$4.6M$276K$2.1M10-Q 2025-11-14
Q2 2025
2025-06-30
$409K-$4.6M-$4.4M$3.2M$6.1M$1.9M10-Q 2026-08-14
Q1 2025
2025-03-31
$341K-$5.9M-$4.8M$3.8M$5.8M$1.7M10-Q 2026-05-08
Q4 2024
2024-12-31
$582K-$5.1M-$5.1M$3.5M$10.8M$1.6M10-K 2026-03-31
Q3 2024
2024-09-30
$555K-$5.4M-$5.5M$7.6MNo debt tags$1.3M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-09-29
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-13
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 346 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.6%
1 month-19.3%
3 months-38.0%
Year to date-87.7%
1 year-91.4%
From 52-week high-93.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SINTSiNtx Technologies Inc.$1.34-1.11%$10.1M
DRIODarioHealth Corp.$1.15-8.73%$13.0M
GUTSFractyl Health Inc.$0.9918+9.76%$13.2M
PLSMPulsenmore Ltd.$1.41+2.17%$9.2M
PAVMPAVmed Inc.$1.75+7.36%$14.0M
AEMDAethlon Medical Inc.$5.01-5.29%$8.1M
CTSOCytosorbents Corporation$4.85-0.41%$15.3M
SNWVSANUWAVE Health Inc.$1.81-0.55%$15.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier